[3-min read] Psychedelic facilitators explain the rationale for eye masks.
[5-min read] Maryland task force proposes three-phased approach to psychedelic legalization.
[5-min read] Q&A with Jhaimy Alvarez-Acosta, Andean Wisdom Keeper
[3-min read] Psychedelic facilitators break down the key elements of set and setting.
[5-min read] Arizona-funded clinical trial will test whole psilocybin mushrooms for PTSD.
[5-min read] Q&A with Raghu Markus, Seeker & Producer
[3-min read] Facilitators comment on the ideal age range for psychedelic use.
[5-min read] Ketamine company receives one of nine FDA Commissioner's National Priority Vouchers.
[5-min read] Q&A with Joe Moore, CEO & Cofounder
[3-min read] Psychedelic facilitators explain when to journey with support and when to go solo.
[5-min read] atai receives FDA's seventh breakthrough therapy designation for a psychedelic drug.
[5-min read] Q&A with Mikki Vogt, Clinical Facilitator & Founder
